Initial bradykinin triggers calcium-induced calcium release in C6 glioma cells and its significance.
- Author:
Yi-Bao WANG
1
;
Yun-Hui LIU
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Bradykinin; pharmacology; Calcium; metabolism; Cell Line, Tumor; Glioma; pathology; Intracellular Fluid; drug effects; Nitric Oxide; metabolism; Rats; Ryanodine; pharmacology; Spectrometry, Fluorescence; methods; Time Factors
- From:Neuroscience Bulletin 2009;25(1):21-26
- CountryChina
- Language:English
-
Abstract:
OBJECTIVETo investigate the underlying mechanism for the selective modulation of the permeability of blood-tumor barrier (BTB) by small dose of bradykinin (BK).
METHODSC6 glioma cells were treated with BK, and changes of intracellular nitric oxide (NO) and intracellular calcium level were measured with fluorescent spectrophotometer.
RESULTSThe initial application of BK easily triggered extracellular calcium influx, which resulted in intracellular calcium store release in C6 glioma cells. The above mechanism was also named ryanodine mediated calcium induced calcium release (CICR). We also detected a long-lasting intracellular NO elevation in C6 glioma cells upon BK treatment. Further study showed that ryanodine mediated CICR contributed greatly to the secondary NO elevation induced by BK treatment.
CONCLUSIONThese results suggested that BK triggered CICR in C6 glioma cells and the associated NO generation might be the underlying mechanism for the selective modulation of BTB permeability by BK.
